Analysis
Filter results by
Search HelpKeyword(s)
Subject
Year of publication
Author(s)
Survey or statistical program
- Biotechnology Use and Development Survey (54)
- Survey of Innovation (14)
- Survey of Advanced Technology (7)
- Characteristics of Growth Firms (7)
- Survey of Biotechnology Use in Canadian Industries (5)
- Bioproducts Production and Development Survey (5)
- Annual Survey of Research and Development in Canadian Industry (4)
- Federal Science Expenditures and Personnel, Activities in the Social Sciences and Natural Sciences (4)
- Survey of Digital Technology and Internet Use (3)
- Functional Foods and Natural Health Products Survey (3)
- Provincial Government Activities in the Natural Sciences (2)
- Survey of Knowledge Management Practices (2)
- Research and Development of Canadian Private Non-Profit Organizations (1)
- Scientific Activities of Provincial Research Organizations, Activities in Natural Sciences and Engineering (1)
- Scientific and Technological Activities of Provincial Governments (1)
- Survey of Intellectual Property Commercialization in the Higher Education Sector (1)
- National Graduates Survey (1)
Results
All (111)
All (111) (60 to 70 of 111 results)
- Articles and reports: 88-003-X200700210325Geography: CanadaDescription:
Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.
Release date: 2007-10-09 - Articles and reports: 88-003-X20060029246Geography: CanadaDescription:
While firms engaged in R&D services are part of the population of firms covered by the Research and Development in Canadian Industry (RDCI) survey and the Biotechnology Use and Development Survey (BUDS), this industry group is not covered by a typical industry survey. This means that there are no industry-specific figures for contribution to GDP or other typical measures of industrial activities and finances. However, data for the industry group are available from the Survey of Innovation 2003, along with other selected professional services. Data from that survey indicate that the establishments in R&D services in physical, engineering and life sciences may be part of a select and highly atypical group of firms and are discussed in this article.
Release date: 2006-06-27 - 63. Coming of age - biotech revenues are on the rise ArchivedArticles and reports: 88-003-X20030016476Geography: CanadaDescription:
Canadian biotechnology is gaining momentum. More firms are getting their products onto the markets and increasing revenues. With the human health sector leading the way, biotechnology revenues rose by a massive 343% for the 1997 to 2001 period, reaching $3.5 billion in 2001. During this same period, the number of firms increased by 33%.
Release date: 2003-02-18 - Stats in brief: 88-001-X20020037899Description:
Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2000-2001 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy.
Release date: 2002-05-01 - 65. Canadian biotech firms: Extent of networking activities and commercialization obstacles ArchivedArticles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - Articles and reports: 21-004-X20010035613Geography: Canada, Province or territoryDescription:
The most widely discussed agricultural topic in recent years is the risks and opportunities presented by food products obtained through biotechnology, especially those derived from genetically modified seeds (GMS). According to the June 2000 survey on field crops, 16% of all soybean acreage in Quebec, and 18% of that in Ontario, was planted with genetically modified seeds. The percentage of corn in both provinces was 27%. Most farms using GMS corn and soybeans are located in Ontario and Quebec where the production of both of these crops is concentrated.
Release date: 2001-03-29 - Articles and reports: 88-003-X19990014629Geography: CanadaDescription:
The growth of the Canadian economy depends largely on scientific and technological innovation in its knowledge-based industries. Research and development in the aerospace, environmental technology, information technology, biotechnology and telecommunications industries requires a highly qualified labour force with the right skills. A new paper reveals how well we're doing matching skills to demand.
Release date: 1999-07-23 - 68. The Canadian Bioproducts Industry, 2003 and 2006 ArchivedArticles and reports: 21-004-X200900110875Geography: CanadaDescription:
This study is a comparative analysis based on data from the Statistics Canada Bioproducts Development Survey (2003) and the Bioproducts Development and Production Survey 2006. This study examines the current state of the domestic industry, changes occurring over the period, and implications for agriculture.
Release date: 2009-06-11 - Articles and reports: 88-003-X200700210324Geography: CanadaDescription:
Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.
Release date: 2007-10-09 - 70. Defining bioproducts: a daunting challenge ArchivedArticles and reports: 88-003-X20060039534Geography: CanadaDescription:
Bioproducts play an important role in the search for solutions to declining reserves of oil, increasing costs of oil extraction, increasing oil prices and increasing greenhouse gas (GHG) concentration. They also offer opportunities for rural economic development and diversification for farmers. This article summarizes ongoing work towards improving our understanding of the bioproduct concepts and their definitions.
Release date: 2006-12-06
- Previous Go to previous page of All results
- 1 Go to page 1 of All results
- ...
- 5 Go to page 5 of All results
- 6 Go to page 6 of All results
- 7 (current) Go to page 7 of All results
- 8 Go to page 8 of All results
- 9 Go to page 9 of All results
- ...
- 12 Go to page 12 of All results
- Next Go to next page of All results
Stats in brief (8)
Stats in brief (8) ((8 results))
- 1. Biotechnology scientific activities in the federal government departments and agencies, 2008/2009 ArchivedStats in brief: 88-001-X201000211095Geography: CanadaDescription:
Data for fiscal year 2008/2009 comprise science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology research and development (R&D) and related scientific activities (RSA) in selected federal government departments and agencies.
Release date: 2010-03-10 - 2. Biotechnology scientific activities in federal government departments and agencies, 2007/2008 ArchivedStats in brief: 88-001-X200900110802Geography: CanadaDescription:
Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2007/2008 were collected from selected federal government departments and agencies. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.
Release date: 2009-03-04 - 3. Biotechnology scientific activities in federal government departments and agencies, 2006/2007 ArchivedStats in brief: 88-001-X200800210604Description:
Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2006/2007 were collected from selected federal government departments and agencies.The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.
Release date: 2008-06-02 - 4. Biotechnology scientific activities in federal government departments and agencies, 2005/2006 ArchivedStats in brief: 88-001-X20070039614Description:
Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2005/2006 were collected from selected federal government departments and agencies. This information contributes to the work of the Canadian Biotechnology Strategy. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.
Release date: 2007-05-11 - 5. Biotechnology scientific activities in federal government departments and agencies, 2004/2005 ArchivedStats in brief: 88-001-X20060029114Description:
Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2004/2005 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy. The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.
Release date: 2006-03-09 - 6. Biotechnology scientific activities in federal government departments and agencies, 2003-2004 ArchivedStats in brief: 88-001-X20050037933Description:
Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2003-2004 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy.
The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.
Release date: 2005-05-11 - Stats in brief: 11-001-X2016356942Description: Release published in The Daily – Statistics Canada’s official release bulletinRelease date: 2016-12-21
- Stats in brief: 88-001-X20020037899Description:
Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2000-2001 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy.
Release date: 2002-05-01
Articles and reports (102)
Articles and reports (102) (0 to 10 of 102 results)
- Articles and reports: 22-20-00012024002Description: This article explores trends in patent applications made by Canadian-resident businesses for advanced technologies from 2001 to 2019, drawing on Eurostat's aggregation of high-tech patents. Approximately one-third of applications fall under high-tech categories, the bulk of which were associated with Communication, Computer, and Automated business equipment technologies. While these fields saw growth until 2012, a subsequent decline occurred, notably in Computer and Electronic Product Manufacturing. Biotechnology, Semiconductors, and Lasers showed limited dynamism, while aviation technology applications surged by nearly twentyfold over the period.Release date: 2024-05-21
- 2. Biotechnology spinoffs: Transferring knowledge from universities and government labs to the marketplace ArchivedArticles and reports: 88-003-X200800110581Geography: CanadaDescription:
When an existing firm decides not to commercially develop a discovery, enterprising entrepreneurs may establish a spinoff organization to pursue the venture. Of the 532 biotechnology firms in Canada in 2005, 179 reported that they were spinoffs from another organization.
Release date: 2008-05-22 - Articles and reports: 88-003-X200700210326Geography: CanadaDescription:
Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.
Release date: 2007-10-09 - 4. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey ArchivedArticles and reports: 88-003-X20070019620Geography: Canada, Province or territoryDescription:
Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.
Release date: 2007-05-10 - Articles and reports: 88-003-X20050038769Geography: CanadaDescription:
In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.
Release date: 2005-10-26 - 6. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - 7. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09 - 8. Factors in biotechnology growth: Results of interviews with leaders of high growth biotechnology firms ArchivedArticles and reports: 88-003-X20040037432Geography: CanadaDescription:
This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.
Release date: 2004-10-29 - 9. Biotechnology scientific activities in selected federal government departments and agencies, 2002-2003 ArchivedArticles and reports: 88-001-X20040077864Description:
Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2002-2003 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy. The data collected for biotechnology are composed of research and development (R&D) and related scientific activities (RSA) expenditures, for intramural and extramural activities, by performer, and also the person-years associated with these activities.
Release date: 2004-07-19 - Articles and reports: 88-003-X20040026930Geography: CanadaDescription:
Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.
Release date: 2004-06-30
- Previous Go to previous page of Articles and reports results
- 1 (current) Go to page 1 of Articles and reports results
- 2 Go to page 2 of Articles and reports results
- 3 Go to page 3 of Articles and reports results
- 4 Go to page 4 of Articles and reports results
- 5 Go to page 5 of Articles and reports results
- 6 Go to page 6 of Articles and reports results
- 7 Go to page 7 of Articles and reports results
- ...
- 11 Go to page 11 of Articles and reports results
- Next Go to next page of Articles and reports results
Journals and periodicals (1)
Journals and periodicals (1) ((1 result))
- 1. Innovation Analysis Bulletin ArchivedJournals and periodicals: 88-003-XGeography: CanadaDescription:
The bulletin summarizes and highlights new results in the analysis of science, technology and the information society. The articles cover current issues in science and technology activities, advanced technologies, innovation in industry and electronic media. The bulletin is designed to be easily readable by non-experts.
Release date: 2009-06-05
- Date modified: